Stxbp1/Munc18-1 haploinsufficiency impairs inhibition and mediates key neurological features of STXBP1 encephalopathy
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Mutations in genes encoding synaptic proteins cause many neurodevelopmental disorders, with the majority affecting postsynaptic apparatuses and much fewer in presynaptic proteins. Syntaxin-binding protein 1 (STXBP1, also known as MUNC18-1) is an essential component of the presynaptic neurotransmitter release machinery. De novo heterozygous pathogenic variants in STXBP1 are among the most frequent causes of neurodevelopmental disorders including intellectual disabilities and epilepsies. These disorders, collectively referred to as STXBP1 encephalopathy, encompass a broad spectrum of neurologic and psychiatric features, but the pathogenesis remains elusive. Here we modeled STXBP1 encephalopathy in mice and found that Stxbp1 haploinsufficiency caused cognitive, psychiatric, and motor dysfunctions, as well as cortical hyperexcitability and seizures. Furthermore, Stxbp1 haploinsufficiency reduced cortical inhibitory neurotransmission via distinct mechanisms from parvalbumin-expressing and somatostatin-expressing interneurons. These results demonstrate that Stxbp1 haploinsufficient mice recapitulate cardinal features of STXBP1 encephalopathy and indicate that GABAergic synaptic dysfunction is likely a crucial contributor to disease pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The novel object recognition memory: neurobiology, test procedure, and its modifications
Antunes, M., & Biala, G. (2012) · Cognitive Processing · doi:10.1007/s10339-011-0430-z · Cited by 2,390 · cited 1×
“This task is thought to depend on the hippocampus and cortex (Antunes and Biala, 2012; Cohen and Stackman, 2015).”
BackgroundA conditional knockout resource for the genome-wide study of mouse gene function
Skarnes, W. C., Rosen, B., West, A. P., Koutsourakis, M., Bushell, W., Iyer, V., Mujica, A. O., Thomas, M., Harrow, J., Cox, T., et al. (2011) · Nature · doi:10.1038/nature10163 · Cited by 1,708
De novo mutations in epileptic encephalopathies
Epi4K Consortium, & Epilepsy Phenome/Genome Project (2013) · Nature · doi:10.1038/nature12439 · Cited by 1,514
Prevalence and architecture of de novo mutations in developmental disorders
Study, D. D. D. (2017) · Nature · doi:10.1038/nature21062 · Cited by 1,480 · cited 6×
“Human genetic studies of neurodevelopmental disorders continue to uncover pathogenic variants in genes encoding synaptic proteins (Hoischen et al., 2014; Zhu et al., 2014; Deciphering Developmental Disorders Study, 2015; Deciphering Developmental Disorders Study, 2017; Stessman et al., 2017; Lindy et al., 2018), demon…”
BackgroundInfluentialInterneuron dysfunction in psychiatric disorders
Marín, O. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3155 · Cited by 1,190 · cited 2×
“…widely considered as a primary defect in animal models of autism spectrum disorder, schizophrenia, Down syndrome, and epilepsy among other neurological disorders (Ramamoorthi and Lin, 2011; Marı́n, 2012; Nelson and Valakh, 2015; Paz and Huguenard, 2015; Contestabile et al., 2017; Lee et al., 2017).”
BackgroundLarge-scale discovery of novel genetic causes of developmental disorders
Study, T. D. D. D. (2015) · Nature · doi:10.1038/nature14135 · Cited by 1,124 · cited 7×
“Human genetic studies of neurodevelopmental disorders continue to uncover pathogenic variants in genes encoding synaptic proteins (Hoischen et al., 2014; Zhu et al., 2014; Deciphering Developmental Disorders Study, 2015; Deciphering Developmental Disorders Study, 2017; Stessman et al., 2017; Lindy et al., 2018), demon…”
BackgroundInfluentialRauch, A., Wieczorek, D., Graf, E., Wieland, T., Endele, S., Schwarzmayr, T., Albrecht, B., Bartholdi, D., Beygo, J., Di Donato, N., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61480-9 · Cited by 1,041
Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders
Nelson, S. B., & Valakh, V. (2015) · Neuron · doi:10.1016/j.neuron.2015.07.033 · Cited by 1,001
Equalizing excitation-inhibition ratios across visual cortical neurons
Xue, M., Atallah, B. V., & Scanziani, M. (2014) · Nature · doi:10.1038/nature13321 · Cited by 722 · cited 1×
“To express ChR2 in Pv or Sst interneurons, 200 nl of AAV9-EF1a-DIO-hChR2 (H134R)-P2A-EYFP vectors (3 10(13) genome copies/ml) were injected into the somatosensory cortex of Stxbp1;Pv and Stxbp1;Pv or Stxbp1;Sst and Stxbp1;Sst mice, respectively, at postnatal day 1–5 as previously described (Xue et al., 2014; Messier e…”
MethodSelf-citationMarble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety
Thomas, A., Burant, A., Bui, N., Graham, D., Yuva-Paylor, L. A., & Paylor, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1466-y · Cited by 698 · cited 1×
“The interpretation of marble burying remains controversial, as it may measure anxiety, compulsive-like behavior, or simply digging behavior (Deacon, 2006; Thomas et al., 2009; Wolmarans et al., 2016).”
BackgroundTargeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
Carvill, G. L., Heavin, S. B., Yendle, S. C., McMahon, J. M., O'Roak, B. J., Cook, J., Khan, A., Dorschner, M. O., Weaver, M., Calvert, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2646 · Cited by 687
Varoqueaux, F., Sigler, A., Rhee, J.-S., Brose, N., Enk, C., Reim, K., & Rosenmund, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122623799 · Cited by 619
Stessman, H. A. F., Xiong, B., Coe, B. P., Wang, T., Hoekzema, K., Fenckova, M., Kvarnung, M., Gerdts, J., Trinh, S., Cosemans, N., et al. (2017) · Nature Genetics · doi:10.1038/ng.3792 · Cited by 559 · cited 2×
“Human genetic studies of neurodevelopmental disorders continue to uncover pathogenic variants in genes encoding synaptic proteins (Hoischen et al., 2014; Zhu et al., 2014; Deciphering Developmental Disorders Study, 2015; Deciphering Developmental Disorders Study, 2017; Stessman et al., 2017; Lindy et al., 2018), demon…”
BackgroundDigging and marble burying in mice: simple methods for in vivo identification of biological impacts
Deacon, R. M. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.20 · Cited by 508
High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies
Hamdan, F. F., Myers, C. T., Cossette, P., Lemay, P., Spiegelman, D., Laporte, A. D., Nassif, C., Diallo, O., Monlong, J., Cadieux-Dion, M., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.09.008 · Cited by 445 · cited 2×
“These include Ca-sensor synaptotagmin 1 (SYT1), vesicle priming factor unc-13 homolog A (UNC13A), and all three components of the neuronal SNAREs, syntaxin 1B (STX1B), synaptosome associated protein 25 (SNAP25), and vesicle associated membrane protein 2 (VAMP2) (Rohena et al., 2013; Schubert et al., 2014; Shen et al.,…”
BackgroundEfficacy and Stability of Quantal GABA Release at a Hippocampal Interneuron–Principal Neuron Synapse
Kraushaar, U., & Jonas, P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05594.2000 · Cited by 281 · cited 2×
“Although the short-term synaptic depression is unaltered in Stxbp1 mice, a change in release probability is still possible because at the Pv interneuron synapses the short-term synaptic plasticity during a short train of action potentials is not sensitive to the release probability (Kraushaar and Jonas, 2000; Luthi et…”
BackgroundPrioritization of neurodevelopmental disease genes by discovery of new mutations
Hoischen, A., Krumm, N., & Eichler, E. E. (2014) · Nature Neuroscience · doi:10.1038/nn.3703 · Cited by 149
The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome
Contestabile, A., Magara, S., & Cancedda, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00054 · Cited by 141
Salpietro, V., Malintan, N. T., Llano-Rivas, I., Spaeth, C. G., Efthymiou, S., Striano, P., Vandrovcova, J., Cutrupi, M. C., Chimenz, R., David, E., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.02.016 · Cited by 134
One gene, many neuropsychiatric disorders: lessons from Mendelian diseases
Zhu, X., Need, A. C., Petrovski, S., & Goldstein, D. B. (2014) · Nature Neuroscience · doi:10.1038/nn.3713 · Cited by 131
Cited by
SNAREopathies: Diversity in Mechanisms and Symptoms
Verhage, M., & Sørensen, J. B. (2020) · Neuron · doi:10.1016/j.neuron.2020.05.036 · Cited by 121
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
Turner, T. J., Zourray, C., Schorge, S., & Lignani, G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15168 · Cited by 71
“Models of mutations in synaptic proteins Different Stxbp1+/- mutant mice have been generated that recapitulate disease-causing STXBP1 haploinsufficiency in humans (Chen et al. 2020; Kovacevic et al. 2018; Miyamoto et al. 2017; Orock et al. 2018).”
BackgroundCYFIP2 p.Arg87Cys Causes Neurological Defects and Degradation of CYFIP2
Kang, M., Zhang, Y., Kang, H. R., Kim, S., Ma, R., Yi, Y., Lee, S., Kim, Y., Li, H., Jin, C., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26535 · Cited by 17
“Electroencephalographic Recordings Electroencephalographic (EEG) recordings, quantifications, and seizure scorings were performed as described previously.(13,14)”
Method(2024) · doi:10.7554/elife.88619.3 · Cited by 17
Kádková, A., Murach, J., Østergaard, M., Malsam, A., Malsam, J., Lolicato, F., Nickel, W., Söllner, T. H., & Sørensen, J. B. (2024) · doi:10.7554/elife.88619.2
Metadata
- Authors
- Chen, W., Cai, Z.-L., Chao, E. S., Chen, H., Longley, C. M., Hao, S., Chao, H.-T., Kim, J. H., Messier, J. E., Zoghbi, H. Y., Tang, J., Swann, J. W., & Xue, M.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2020-02-19
- Volume
- 9
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W3008559558
- Cited by
- 89
- References
- 20
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.